Dimitris Moulavasilis Takes Helm of M42
Company - People | May 07, 2025 | EIN
M42, a global leader in AI-driven healthcare, has appointed Dimitris Moulavasilis as its new Group CEO. This follows the successful leadership of Hasan Jasem Al Nowais, who remains on the board after guiding the company's transformative growth. Moulavasilis, formerly involved with M42's Global Patient Care platform and Diaverum, steps into this role with a solid foundation in healthcare leadership and digital transformation. His appointment is seen as a strategic step to continue M42's global expansion and innovation in the healthcare sector. M42's growth trajectory under Al Nowais included significant international expansion and a pivotal merger with G42 Healthcare, setting the stage for further advancements under Moulavasilis's leadership.
Sectors
- Healthcare
- Technology
Geography
- Global – M42 operates on a global scale, having expanded into 26 countries under previous leadership.
- Europe – Moulavasilis has past experience in leading European healthcare operations, such as at Affidea.
Industry
- Healthcare – M42 operates in the healthcare sector, primarily focusing on innovative, AI-driven patient care solutions.
- Technology – The involvement in AI-driven solutions classifies M42's operations within the technology industry, especially in healthcare technology.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Dimitris Moulavasilis | New Group CEO | Person | Appointed as the new Group CEO of M42, with a background in healthcare management. |
| M42 | Company | Company | An AI-driven global health company undergoing leadership transition. |
| Hasan Jasem Al Nowais | Former CEO, Board Member | Person | Former CEO of M42, pivotal in its growth and remains a key figure on its board. |
| Peng Xiao | Chairman of M42, Group CEO of G42 | Person | Chairman of M42 and Group CEO of G42, acknowledges previous leadership contributions. |